Global GERD Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global GERD market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global GERD market 2017 - 2021 ($ million)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
4.3 Drug Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Drug Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
6.4 Parenteral - Market size and forecast 2022-2027
Exhibit 38: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Route of Administration
Exhibit 42: Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 43: Chart on Type - Market share 2022-2027 (%)
Exhibit 44: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 45: Chart on Comparison by Type
Exhibit 46: Data Table on Comparison by Type
7.3 Antacid - Market size and forecast 2022-2027
Exhibit 47: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Antacid - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Antacid - Year-over-year growth 2022-2027 (%)
7.4 PPI - Market size and forecast 2022-2027
Exhibit 51: Chart on PPI - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on PPI - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on PPI - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on PPI - Year-over-year growth 2022-2027 (%)
7.5 H2 receptor antagonist drugs - Market size and forecast 2022-2027
Exhibit 55: Chart on H2 receptor antagonist drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on H2 receptor antagonist drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on H2 receptor antagonist drugs - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on H2 receptor antagonist drugs - Year-over-year growth 2022-2027 (%)
7.6 Pro-Kinetic drugs - Market size and forecast 2022-2027
Exhibit 59: Chart on Pro-Kinetic drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Pro-Kinetic drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Pro-Kinetic drugs - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Pro-Kinetic drugs - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Type
Exhibit 63: Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 65: Chart on Market share by geography 2022-2027 (%)
Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 105: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 108: Overview on factors of disruption
11.4 Industry risks
Exhibit 109: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 110: Vendors covered
12.2 Market positioning of vendors
Exhibit 111: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 112: Abbott Laboratories - Overview
Exhibit 113: Abbott Laboratories - Business segments
Exhibit 114: Abbott Laboratories - Key news
Exhibit 115: Abbott Laboratories - Key offerings
Exhibit 116: Abbott Laboratories - Segment focus
12.4 Alkem Laboratories Ltd.
Exhibit 117: Alkem Laboratories Ltd. - Overview
Exhibit 118: Alkem Laboratories Ltd. - Business segments
Exhibit 119: Alkem Laboratories Ltd. - Key news
Exhibit 120: Alkem Laboratories Ltd. - Key offerings
Exhibit 121: Alkem Laboratories Ltd. - Segment focus
12.5 Apotex Inc.
Exhibit 122: Apotex Inc. - Overview
Exhibit 123: Apotex Inc. - Product / Service
Exhibit 124: Apotex Inc. - Key offerings
12.6 AstraZeneca Plc
Exhibit 125: AstraZeneca Plc - Overview
Exhibit 126: AstraZeneca Plc - Product / Service
Exhibit 127: AstraZeneca Plc - Key news
Exhibit 128: AstraZeneca Plc - Key offerings
12.7 Aurobindo Pharma Ltd.
Exhibit 129: Aurobindo Pharma Ltd. - Overview
Exhibit 130: Aurobindo Pharma Ltd. - Product / Service
Exhibit 131: Aurobindo Pharma Ltd. - Key offerings
12.8 Bayer AG
Exhibit 132: Bayer AG - Overview
Exhibit 133: Bayer AG - Business segments
Exhibit 134: Bayer AG - Key news
Exhibit 135: Bayer AG - Key offerings
Exhibit 136: Bayer AG - Segment focus
12.9 Cipla Ltd.
Exhibit 137: Cipla Ltd. - Overview
Exhibit 138: Cipla Ltd. - Business segments
Exhibit 139: Cipla Ltd. - Key news
Exhibit 140: Cipla Ltd. - Key offerings
Exhibit 141: Cipla Ltd. - Segment focus
12.10 Dr Reddys Laboratories Ltd.
Exhibit 142: Dr Reddys Laboratories Ltd. - Overview
Exhibit 143: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 144: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 145: Dr Reddys Laboratories Ltd. - Segment focus
12.11 Eisai Co. Ltd.
Exhibit 146: Eisai Co. Ltd. - Overview
Exhibit 147: Eisai Co. Ltd. - Business segments
Exhibit 148: Eisai Co. Ltd. - Key offerings
Exhibit 149: Eisai Co. Ltd. - Segment focus
12.12 Fresenius SE and Co. KGaA
Exhibit 150: Fresenius SE and Co. KGaA - Overview
Exhibit 151: Fresenius SE and Co. KGaA - Business segments
Exhibit 152: Fresenius SE and Co. KGaA - Key news
Exhibit 153: Fresenius SE and Co. KGaA - Key offerings
Exhibit 154: Fresenius SE and Co. KGaA - Segment focus
12.13 GlaxoSmithKline Plc
Exhibit 155: GlaxoSmithKline Plc - Overview
Exhibit 156: GlaxoSmithKline Plc - Business segments
Exhibit 157: GlaxoSmithKline Plc - Key offerings
Exhibit 158: GlaxoSmithKline Plc - Segment focus
12.14 iNova Pharmaceuticals
Exhibit 159: iNova Pharmaceuticals - Overview
Exhibit 160: iNova Pharmaceuticals - Product / Service
Exhibit 161: iNova Pharmaceuticals - Key offerings
12.15 Johnson and Johnson
Exhibit 162: Johnson and Johnson - Overview
Exhibit 163: Johnson and Johnson - Business segments
Exhibit 164: Johnson and Johnson - Key news
Exhibit 165: Johnson and Johnson - Key offerings
Exhibit 166: Johnson and Johnson - Segment focus
12.16 Lupin Ltd.
Exhibit 167: Lupin Ltd. - Overview
Exhibit 168: Lupin Ltd. - Product / Service
Exhibit 169: Lupin Ltd. - Key news
Exhibit 170: Lupin Ltd. - Key offerings
12.17 Perrigo Co. Plc
Exhibit 171: Perrigo Co. Plc - Overview
Exhibit 172: Perrigo Co. Plc - Business segments
Exhibit 173: Perrigo Co. Plc - Key news
Exhibit 174: Perrigo Co. Plc - Key offerings
Exhibit 175: Perrigo Co. Plc - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 176: Inclusions checklist
Exhibit 177: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 178: Currency conversion rates for US$
13.4 Research methodology
Exhibit 179: Research methodology
Exhibit 180: Validation techniques employed for market sizing
Exhibit 181: Information sources
13.5 List of abbreviations
Exhibit 182: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global GERD market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Drug Type Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits 31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Route of Administration
Exhibits 33: Data Table on Comparison by Route of Administration
Exhibits 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Route of Administration ($ million)
Exhibits 43: Chart on Type - Market share 2022-2027 (%)
Exhibits 44: Data Table on Type - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Type
Exhibits 46: Data Table on Comparison by Type
Exhibits 47: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Antacid - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Antacid - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on PPI - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on PPI - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on PPI - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on PPI - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on H2 receptor antagonist drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on H2 receptor antagonist drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on H2 receptor antagonist drugs - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on H2 receptor antagonist drugs - Year-over-year growth 2022-2027 (%)
Exhibits 59: Chart on Pro-Kinetic drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Data Table on Pro-Kinetic drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Chart on Pro-Kinetic drugs - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on Pro-Kinetic drugs - Year-over-year growth 2022-2027 (%)
Exhibits 63: Market opportunity by Type ($ million)
Exhibits 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 65: Chart on Market share by geography 2022-2027 (%)
Exhibits 66: Data Table on Market share by geography 2022-2027 (%)
Exhibits 67: Chart on Geographic comparison
Exhibits 68: Data Table on Geographic comparison
Exhibits 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 105: Market opportunity by geography ($ million)
Exhibits 106: Impact of drivers and challenges in 2022 and 2027
Exhibits 107: Overview on Criticality of inputs and Factors of differentiation
Exhibits 108: Overview on factors of disruption
Exhibits 109: Impact of key risks on business
Exhibits 110: Vendors covered
Exhibits 111: Matrix on vendor position and classification
Exhibits 112: Abbott Laboratories - Overview
Exhibits 113: Abbott Laboratories - Business segments
Exhibits 114: Abbott Laboratories - Key news
Exhibits 115: Abbott Laboratories - Key offerings
Exhibits 116: Abbott Laboratories - Segment focus
Exhibits 117: Alkem Laboratories Ltd. - Overview
Exhibits 118: Alkem Laboratories Ltd. - Business segments
Exhibits 119: Alkem Laboratories Ltd. - Key news
Exhibits 120: Alkem Laboratories Ltd. - Key offerings
Exhibits 121: Alkem Laboratories Ltd. - Segment focus
Exhibits 122: Apotex Inc. - Overview
Exhibits 123: Apotex Inc. - Product / Service
Exhibits 124: Apotex Inc. - Key offerings
Exhibits 125: AstraZeneca Plc - Overview
Exhibits 126: AstraZeneca Plc - Product / Service
Exhibits 127: AstraZeneca Plc - Key news
Exhibits 128: AstraZeneca Plc - Key offerings
Exhibits 129: Aurobindo Pharma Ltd. - Overview
Exhibits 130: Aurobindo Pharma Ltd. - Product / Service
Exhibits 131: Aurobindo Pharma Ltd. - Key offerings
Exhibits 132: Bayer AG - Overview
Exhibits 133: Bayer AG - Business segments
Exhibits 134: Bayer AG - Key news
Exhibits 135: Bayer AG - Key offerings
Exhibits 136: Bayer AG - Segment focus
Exhibits 137: Cipla Ltd. - Overview
Exhibits 138: Cipla Ltd. - Business segments
Exhibits 139: Cipla Ltd. - Key news
Exhibits 140: Cipla Ltd. - Key offerings
Exhibits 141: Cipla Ltd. - Segment focus
Exhibits 142: Dr Reddys Laboratories Ltd. - Overview
Exhibits 143: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 144: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 145: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 146: Eisai Co. Ltd. - Overview
Exhibits 147: Eisai Co. Ltd. - Business segments
Exhibits 148: Eisai Co. Ltd. - Key offerings
Exhibits 149: Eisai Co. Ltd. - Segment focus
Exhibits 150: Fresenius SE and Co. KGaA - Overview
Exhibits 151: Fresenius SE and Co. KGaA - Business segments
Exhibits 152: Fresenius SE and Co. KGaA - Key news
Exhibits 153: Fresenius SE and Co. KGaA - Key offerings
Exhibits 154: Fresenius SE and Co. KGaA - Segment focus
Exhibits 155: GlaxoSmithKline Plc - Overview
Exhibits 156: GlaxoSmithKline Plc - Business segments
Exhibits 157: GlaxoSmithKline Plc - Key offerings
Exhibits 158: GlaxoSmithKline Plc - Segment focus
Exhibits 159: iNova Pharmaceuticals - Overview
Exhibits 160: iNova Pharmaceuticals - Product / Service
Exhibits 161: iNova Pharmaceuticals - Key offerings
Exhibits 162: Johnson and Johnson - Overview
Exhibits 163: Johnson and Johnson - Business segments
Exhibits 164: Johnson and Johnson - Key news
Exhibits 165: Johnson and Johnson - Key offerings
Exhibits 166: Johnson and Johnson - Segment focus
Exhibits 167: Lupin Ltd. - Overview
Exhibits 168: Lupin Ltd. - Product / Service
Exhibits 169: Lupin Ltd. - Key news
Exhibits 170: Lupin Ltd. - Key offerings
Exhibits 171: Perrigo Co. Plc - Overview
Exhibits 172: Perrigo Co. Plc - Business segments
Exhibits 173: Perrigo Co. Plc - Key news
Exhibits 174: Perrigo Co. Plc - Key offerings
Exhibits 175: Perrigo Co. Plc - Segment focus
Exhibits 176: Inclusions checklist
Exhibits 177: Exclusions checklist
Exhibits 178: Currency conversion rates for US$
Exhibits 179: Research methodology
Exhibits 180: Validation techniques employed for market sizing
Exhibits 181: Information sources
Exhibits 182: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global GERD market: Bayer AG, Alkem Laboratories Ltd., Apotex Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, iNova Pharmaceuticals, Johnson and Johnson, Lupin Ltd., Perrigo Co. Plc, Pfizer Inc., SRS Life Sciences Pte. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., The Procter and Gamble Co., and Abbott Laboratories.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rising prevalence of obesity.`

According to the report, one of the major drivers for this market is the rising geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• Bayer AG
• Alkem Laboratories Ltd.
• Apotex Inc.
• AstraZeneca Plc
• Aurobindo Pharma Ltd.
• Cipla Ltd.
• Dr Reddys Laboratories Ltd.
• Eisai Co. Ltd.
• Fresenius SE and Co. KGaA
• GlaxoSmithKline Plc
• iNova Pharmaceuticals
• Johnson and Johnson
• Lupin Ltd.
• Perrigo Co. Plc
• Pfizer Inc.
• SRS Life Sciences Pte. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.
• The Procter and Gamble Co.
• Abbott Laboratories